Advertisement

The role of Optical Coherence Tomography in Parkinsonism: A critical review

      Abstract

      Optical coherence tomography (OCT) has been evaluated as a tool to assess retinal changes in various neurodegenerative disorders. Parkinson's disease (PD), is a neurodegenerative disorder wherein dopaminergic deficiency results in some of the symptoms. As retina also has high concentration of dopamine, it would be of interest for both the clinician as well as the basic scientist to know if there is a correlation between the clinical features and the retinal changes. The objective of this review is to critically evaluate the literature and study the utility of OCT as a tool to evaluate retinal changes in PD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jankovic J.
        Parkinson's disease: clinical features and diagnosis.
        J. Neurol. Neurosurg. Psychiatry. 2008; 79: 368-376
        • Chaudhuri K.R.
        • Healy D.G.
        • Schapira A.H.
        National Institute for clinical excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management.
        Lancet Neurol. 2006; 5: 235-245
        • Litvan I.
        What is an atypical parkinsonian disorder?.
        in: Litvan I. Atypical Parkinsonian Disorders: Clinical and Research Aspects. Humana Press, New Jersey2005: 1-9
        • Djamgoz M.B.
        • Hankins M.W.
        • Hirano J.
        • Archer S.N.
        Neurobiology of retinal dopamine in relation to degenerative states of the tissue.
        Vis. Res. 1997; 37: 3509-3529
        • Harnois C.
        • Di Paolo T.
        Decreased dopamine in the retinas of patients with Parkinson's disease.
        Invest. Ophthalmol. Vis. Sci. 1990; 31: 2473-2475
        • Huang D.
        • Swanson E.A.
        • Lin C.P.
        • Schuman J.S.
        • Stinson W.G.
        • Chang W.
        • et al.
        Optical coherence tomography.
        Science. 1991; 254: 1178-1181
        • Balcer L.J.
        • Balk L.J.
        • Brandt A.U.
        • Calabresi P.A.
        • Martinez-Lapiscina E.H.
        • Nolan R.C.
        • Paul F.
        • Petzold A.
        • Saidha S.
        The international multiple sclerosis visual system consortium: advancing visual system research in multiple sclerosis.
        J. Neuroophthalmol. 2018 Dec; 38: 494-501https://doi.org/10.1097/WNO.0000000000000732
        • Waldman A.T.
        • Liu G.T.
        • Lavery A.M.
        • Liu G.
        • Gaetz W.
        • Aleman T.S.
        • Banwell B.L.
        Optical coherence tomography and visual evoked potentials in pediatric MS.
        Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5; 4e356https://doi.org/10.1212/NXI.0000000000000356
        • Oertel F.C.
        • Zimmermann H.
        • Paul F.
        • Brandt A.U.
        Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.
        EPMA J. 2017 Dec 22; 9: 21-33https://doi.org/10.1007/s13167-017-0123-5
        • You Y.
        • Graham E.C.
        • Shen T.
        • Yiannikas C.
        • Parratt J.
        • Gupta V.
        • Barton J.
        • Dwyer M.
        • Barnett M.H.
        • Fraser C.L.
        • Graham S.L.
        • Klistorner A.
        Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS.
        Neurol Neuroimmunol Neuroinflamm. 2017 Dec 15; 5e427https://doi.org/10.1212/NXI.0000000000000427
        • Oberwahrenbrock T.
        • Traber G.L.
        • Lukas S.
        • Gabilondo I.
        • Nolan R.
        • Songster C.
        • Balk L.
        • Petzold A.
        • Paul F.
        • Villoslada P.
        • Brandt A.U.
        • Green A.J.
        • Schippling S.
        Multicenter reliability of semiautomatic retinal layer segmentation using OCT.
        Neurol Neuroimmunol Neuroinflamm. 2018 Mar 13; 5e449https://doi.org/10.1212/NXI.0000000000000449
        • Kromer R.
        • Buhmann C.
        • Hidding U.
        • Keserü M.
        • Keserü D.
        • Hassenstein A.
        • Stemplewitz B.
        Evaluation of retinal vessel morphology in patients with Parkinson's disease using optical coherence tomography.
        PLoS One. 2016 Aug 15; 11e0161136
      1. Maria Pilar Bambo, Elena Garcia-Martin, Maria Satue, Susana Perez-Olivan, Silvia Alayon, Marta Gonzalez-Hernandez, Vicente Polo, Jose Manuel Larrosa and Manuel Gonzalez-De la Rosa.Measuring hemoglobin levels in the optic disc of parkinson's disease patients using new colorimetric analysis software.

        • Archibald N.K.
        • Clarke M.P.
        • Mosimann U.P.
        • Burn D.J.
        Retinal thickness in Parkinson's disease.
        Parkinsonism Relat. Disord. 2011; 17: 431-436
        • Aaker G.D.
        • Myung J.S.
        • Kiss S.
        Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.
        Clin. Ophthalmol. 2010; 4: 1427-1432
        • Albrecht P.
        • Muller A.K.
        • Sudmeyer M.
        • Ferrea S.
        • Ringelstein M.
        • Cohn E.
        Optical coherence tomography in parkinsonian syndromes.
        PLos One. 2012; 7e34891
        • Pillai J.A.
        • Bermel R.
        • Bonner-Jackson A.
        • Rae-Grant A.
        • Fernandez H.
        • Bena J.
        • Jones S.E.
        • Ehlers J.P.
        • Leverenz J.B.
        Retinal nerve fiber layer thinning in Alzheimer's disease: a case-control study in comparison to normal aging, Parkinson's disease, and non-Alzheimer's dementia.
        Am. J. Alzheimers Dis. Other Dement. 2016 Aug; 31: 430-436
        • Mailankody P.
        • Battu R.
        • Khanna A.
        • Lenka A.
        • Yadav R.
        • Pal P.K.
        Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
        Parkinsonism Relat. Disord. 2015 Oct; 21: 1164-1169
        • Tsironi E.E.
        • Dastiridou A.
        • Katsanos A.
        • Dardiotis E.
        • Veliki S.
        • Patramani G.
        • et al.
        Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease.
        BMC Ophthalmol. 2012; 12
        • Bittersohl D.
        • Stemplewitz B.
        • Keserü M.
        • Buhmann C.
        • Richard G.
        • Hassenstein A.
        Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and Heidelberg retina tomography.
        Acta Ophthalmol. 2015 Nov; 93: e578-e584
        • Yang Z.J.
        • Wei J.
        • Mao C.J.
        • Zhang J.R.
        • Chen J.
        • Ji X.Y.
        • Liu J.Y.
        • Shen Y.
        • Xiong K.P.
        • Huang J.Y.
        • Yang Y.P.
        • Liu C.F.
        Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.
        Sleep Breath. 2016 Jun; 3
        • Lee J.Y.
        • Kim J.M.
        • Ahn J.
        • Kim H.J.
        • Jeon B.S.
        • Kim T.W.
        Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's disease.
        Mov. Disord. 2014 Jan; 29: 61-67
        • Chorostecki J.
        • Seraji-Bozorgzad N.
        • Shah A.
        • Bao F.
        • Bao G.
        • George E.
        • Gorden V.
        • Caon C.
        • Frohman E.
        • Bhatti MTKhan O.
        Characterization of retinal architecture in Parkinson's disease.
        J. Neurol. Sci. 2015 Aug 15; 355: 44-48
        • Garcia-Martin E.
        • Rodriguez-Mena D.
        • Satue M.
        • Almarcegui C.
        • Dolz I.
        • Alarcia R.
        • et al.
        Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
        Invest. Ophthalmol. Vis. Sci. 2014; 55: 696-705
        • Satue M.
        • Garcia-Martin E.
        • Fuertes I.
        • Otin S.
        • Alarcia R.
        • Herrero R.
        • et al.
        Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients.
        Eye (Lond). 2013; 27: 507-514
        • Kirbas S.
        • Turkyilmaz K.
        • Tufekci A.
        • Durmus M.
        Retinal nerve fiber layer thickness in Parkinson disease.
        J. Neuroophthalmol. 2013; 33: 62-65
        • La Morgia C.
        • Barboni P.
        • Rizzo G.
        • Carbonelli M.
        • Savini G.
        • Scaglione C.
        • et al.
        Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?.
        Eur. J. Neurol. 2013; 20: 198-201
        • Eraslan M.
        • Balci S.Y.
        • Cerman E.
        • Temel A.
        • Suer D.
        • Elmaci N.T.
        Comparison of optical coherence tomography findings in patients with primary open-angle glaucoma and parkinson disease.
        J. Glaucoma. 2016 Jul; 25: e639-e646
        • Mendoza-Santiesteban C.E.
        • Palma J.A.
        • Martinez J.
        • Norcliffe-Kaufmann L.
        • Hedges III, T.R.
        • Kaufmann H.
        Progressive retinal structure abnormalities in multiple system atrophy.
        Mov. Disord. 2015 Dec; 30: 1944-1953
        • Moschos M.M.
        • Tagaris G.
        • Markopoulos I.
        • Margetis I.
        • Tsapakis S.
        • Kanakis M.
        • et al.
        Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.
        Eur. J. Ophthalmol. 2011; 21: 24-29
        • Bayhan H.A.
        • Aslan Bayhan S.
        • Tanık N.
        • Gürdal C.
        The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
        Curr. Eye Res. 2014 Nov; 39: 1117-1122
        • Sari E.S.
        • Koc R.
        • Yazici A.
        • Sahin G.
        • Ermis S.S.
        Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.
        J. Neuroophthalmol. 2015 Jun; 35: 117-121
        • Yavas G.F.
        • Yilmaz O.
        • Küsbeci T.
        • Oztürk F.
        The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease.
        Eur. J. Ophthalmol. 2007 Sep-Oct; 17: 812-816
        • Aydin T.S.
        • Umit D.
        • Nur O.M.
        • Fatih U.
        • Asena K.
        • Nefise O.Y.
        • Serpil Y.
        Optical coherence tomography findings in Parkinson's disease.
        Kaohsiung J. Med. Sci. 2018 Mar; 34: 166-171
        • Gulmez Sevim D.
        • Unlu M.
        • Sonmez S.
        • Gultekin M.
        • Karaca C.
        • Ozturk Oner A.
        Retinal vessel diameter obtained by optical coherence tomography is spared in Parkinson's disease.
        Int Ophthalmol. 2019 April; 34: 813-819
        • Unlu M.
        • Gulmez Sevim D.
        • Gultekin M.
        • Karaca C.
        Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson's disease.
        Neurol. Sci. 2018 Mar; 39: 533-541
        • Ma L.J.
        • Xu L.L.
        • Mao C.J.
        • Fu Y.T.
        • Ji X.Y.
        • Shen Y.
        • Chen J.
        • Yang Y.P.
        • Liu C.F.
        Progressive changes in the retinal structure of patients with Parkinson's disease.
        J. Park. Dis. 2018; 8: 85-92
        • Rohani M.
        • Langroodi A.S.
        • Ghourchian S.
        • Falavarjani K.G.
        • Soudi R.
        • Shahidi G.
        Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease.
        Neurol. Sci. 2013; 34: 689-693
        • Matlach J.
        • Wagner M.
        • Malzahn U.
        • Schmidtmann I.
        • Steigerwald F.
        • Musacchio T.
        • Volkmann J.
        • Grehn F.
        • Göbel W.
        • Klebe S.
        Retinal changes in Parkinson's disease and glaucoma.
        Parkinsonism Relat Disord. 2018 Nov; 56: 41-46
        • Moschos M.M.
        • Chatziralli I.P.
        Evaluation of choroidal and retinal thickness changes in Parkinson's disease using spectral domain optical coherence tomography.
        Semin. Ophthalmol. 2018; 33: 494-497
        • Jiménez B.
        • Ascaso F.J.
        • Cristóbal J.A.
        • López del Val J.
        Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
        Mov. Disord. 2014; 29: 68-74
        • Cubo E.
        • Tedejo R.P.
        • Rodriguez Mendez V.
        • López Peña M.J.
        • Trejo Gabriel Y Galán JM.
        Retina thickness in Parkinson's disease and essential tremor.
        Mov. Disord. 2010; 25: 2461-2462
        • Pilat A.
        • McLean R.J.
        • Proudlock F.A.
        • Maconachie G.D.
        • Sheth V.
        • Rajabally Y.A.
        • Gottlob I.
        In vivo morphology of the optic nerve and retina in patients with Parkinson's disease.
        Invest. Ophthalmol. Vis. Sci. 2016 Aug 1; 57: 4420-4427
        • Inzelberg R.
        • Ramirez J.A.
        • Nisipeanu P.
        • Ophir A.
        Retinal nerve fiber layer thinning in Parkinson disease.
        Vis. Res. 2004; 44: 2793-2797
        • Roth N.M.
        • Saidha S.
        • Zimmermann H.
        • Brandt A.U.
        • Isensee J.
        • Benkhellouf-Rutkowska A.
        • Dornauer M.
        • Kühn A.A.
        • Müller T.
        • Calabresi P.A.
        • Paul F.
        Photoreceptor layer thinning in idiopathic Parkinson's disease.
        Mov. Disord. 2014; 29: 1163-1170
        • Ucak T.
        • Alagoz A.
        • Cakir B.
        • Celik E.
        • Bozkurt E.
        • Alagoz G.
        Analysis of the retinal nerve fiber and ganglion cell - Inner plexiform layer by optical coherence tomography in Parkinson's patients.
        Parkinsonism Relat Disord. 2016; 31: 59-64
        • Schneider M.
        • Müller H.P.
        • Lauda F.
        • Tumani H.
        • Ludolph A.C.
        • Kassubek J.
        • Pinkhardt E.H.
        Retinal single-layer analysis in parkinsonian syndromes: an optical coherence tomography study.
        J. Neural Transm. (Vienna). 2014 Jan; 121: 41-47
        • Moreno-Ramos T.
        • Benito-León J.
        • Villarejo A.
        • Bermejo-Pareja F.
        Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
        J. Alzheimers Dis. 2013; 34: 659-664
        • Kopal Aleš
        • Mejzlíková Eva
        • Preiningerová Jana Lízrová
        • Brebera David
        • Ulmanová Olga
        • Ehler Edvard
        • Roth Jan
        Changes of retina are not involved in the genesis of visual hallucinations in parkinson's disease.
        Parkinsons Dis. 2015; : 709191
        • Shrier E.M.
        • Adam C.R.
        • Spund B.
        • Glazman S.
        • Bodis-Wollner I.
        Interocular asymmetry of foveal thickness in Parkinson disease.
        J Ophthalmol. 2012; : 728457
        • Sen A.
        • Tugcu B.
        • Coskun C.
        • Ekinci C.
        • Nacaroglu S.A.
        Effects of levodopa on retina in Parkinson disease.
        Eur. J. Ophthalmol. 2014 Jan-Feb; 24: 114-119
        • Gulmez Sevim D.
        • Unlu M.
        • Gultekin M.
        • Karaca C.
        • Mirza M.
        • Mirza G.E.
        Evaluation of retinal changes in progressive Supranuclear palsy and Parkinson disease.
        J. Neuroophthalmol. 2017 Dec; 12
        • Satue M.
        • Rodrigo M.J.
        • Obis J.
        • Vilades E.
        • Gracia H.
        • Otin S.
        • Fuertes M.I.
        • Alarcia R.
        • Crespo J.A.
        • Polo V.
        • Larrosa J.M.
        • Pablo L.E.
        • Garcia-Martin E.
        Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson's disease.
        Invest. Ophthalmol. Vis. Sci. 2017 Feb 1; 58: 1151-1157
        • Altintaş O.
        • Işeri P.
        • Ozkan B.
        • Cağlar Y.
        Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.
        Doc. Ophthalmol. 2008; 116: 137-146
        • Hajee M.E.
        • March W.F.
        • Lazzaro D.R.
        • Wolintz A.H.
        • Shrier E.M.
        • Bodis-Wollner
        • et al.
        Inner retinal layer thinning in Parkinson disease.
        Arch. Ophthalmol. 2009; 127: 737-741
        • Adam C.R.
        • Shrier E.
        • Ding Y.
        • Glazman S.
        • Bodis-Wollner I.
        Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
        J. Neuroophthalmol. 2013; 33: 137-142
        • Ahn J.
        • Lee J.Y.
        • Kim T.W.
        • Yoon E.J.
        • Oh S.
        • Kim Y.K.
        • Kim J.M.
        • Woo S.J.
        • Kim K.W.
        • Jeon B.
        Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
        Neurology. 2018 Sep 11; 91 (doi: 10.1212): e1003-e1012
        • Martínez-Navarrete G.C.
        • Martín-Nieto J.
        • Esteve-Rudd J.
        • Angulo A.
        • Cuenca N.
        Alpha synuclein gene expression profile in the retina of vertebrates.
        Mol. Vis. 2007 Jun 18; 13: 949-961
        • Spund B.
        • Ding Y.
        • Liu T.
        • Selesnick I.
        • Glazman S.
        • Shrier E.M.
        • Bodis-Wollner I.
        Remodeling of the fovea in Parkinson disease.
        J. Neural Transm. (Vienna). 2013 May; 120: 745-753
        • Ding Y.
        • Spund B.
        • Glazman S.
        • Shrier E.M.
        • Miri S.
        • Selesnick I.
        • Bodis-Wollner I.
        Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease.
        J. Neural Transm. (Vienna). 2014 Nov; 121: 1367-1376
        • Fischer M.D.
        • Synofzik M.
        • Kernstock C.
        • Dietzsch J.
        • Heidlauf R.
        • Schicks J.
        • Srulijes K.
        • Wiethoff S.
        • Menn O.
        • Berg D.
        • Schöls L.
        • Schiefer U.
        Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy.
        Graefes Arch. Clin. Exp. Ophthalmol. 2013 Jan; 251: 235-241
        • Ahn J.
        • Lee J.Y.
        • Kim T.W.
        Retinal thinning correlates with clinical severity in multiple system atrophy.
        J. Neurol. 2016 Jul; 14
        • Pula John H.
        • Towle Vernon L.
        • Staszak Victoria M.
        • Cao Dingcai
        • Bernard Jacqueline T.
        • Gomez Christopher M.
        Retinal nerve fibre layer and macular thinning in spinocerebellar Ataxia and cerebellar multisystem atrophy.
        Neuroophthalmology. 2011 Jun; 35: 108-114
        • Silveira L.C.
        • Saito C.A.
        • Lee B.B.
        • et al.
        Morphology and physiology of primate M- and P-cells.
        Prog. Brain Res. 2004; 144: 21-46
        • Mendoza-Santiesteban C.E.
        • Palma J.A.
        • Ortuño-Lizarán I.
        • Cuenca N.
        • Kaufmann H.
        Pathologic confirmation of retinal ganglion cell loss in multiple system atrophy.
        Neurology. 2017 Jun 6; 88: 2233-2235https://doi.org/10.1212/WNL.0000000000004020
        • Stemplewitz B.
        • Kromer R.
        • Vettorazzi E.
        • Hidding U.
        • Frings A.
        • Buhmann C.
        Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry.
        Sci. Rep. 2017 Jul 13; 7: 535
        • Kaur M.
        • Saxena R.
        • Singh D.
        • Behari M.
        • Sharma P.
        • Menon V.
        Correlation between structural and functional retinal changes in Parkinson disease.
        J. Neuroophthalmol. 2015 Sep; 35: 254-258
        • Miri S.
        • Glazman S.
        • Mylin L.
        • Bodis-Wollner I.
        A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
        Parkinsonism Relat. Disord. 2016 Jan; 22: S134-S137
        • Polo V.
        • Satue M.
        • Rodrigo M.J.
        • Otin S.
        • Alarcia R.
        • Bambo M.P.
        • Fuertes M.I.
        • Larrosa J.M.
        • Pablo L.E.
        • Garcia-Martin E.
        Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
        BMJ Open. 2016 May 6; 6e009658
        • Garcia-Martin E.
        • Larrosa J.M.
        • Polo V.
        • Satue M.
        • Marques M.L.
        • Alarcia R.
        • Seral M.
        • Fuertes I.
        • Otin S.
        • Pablo L.E.
        Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration.
        Am J Ophthalmol. 2014 Feb; 157 (470-478.e2)
        • Coppola G.
        • Di Renzo A.
        • Ziccardi L.
        • Martelli F.
        • Fadda A.
        • Manni G.
        • Barboni P.
        • Pierelli F.
        • Sadun A.A.
        • Parisi V.
        Optical coherence tomography in Alzheimer's disease: a meta-analysis.
        PLoS One. 2015 Aug 7; 10e0134750
        • Salobrar-Garcia E.
        • Hoyas I.
        • Leal M.
        • de Hoz R.
        • Rojas B.
        • Ramirez A.I.
        • Salazar J.J.
        • Yubero R.
        • Gil P.
        • Triviño A.
        • Ramirez J.M.
        Analysis of retinal peripapillary segmentation in early alzheimer's disease patients.
        Biomed Res Int. 2015; : 636548
        • Ratchford J.N.
        • Quigg M.E.
        • Conger A.
        • Frohman T.
        • Frohman E.
        • Balcer L.J.
        • Calabresi P.A.
        • Kerr D.A.
        Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.
        Neurology. 2009 Jul 28; 73: 302-308
        • Andrade C.
        • Beato J.
        • Monteiro A.
        • Costa A.
        • Penas S.
        • Guimarães J.
        • Reis F.F.
        • Garrett C.
        Spectral-domain optical coherence tomography as a potential biomarker in Huntington's disease.
        Mov. Disord. 2016 Mar; 31: 377-383
        • Miri Shahnaz
        • Shrier Eric M.
        • Glazman Sofya
        • Ding Yin
        • Selesnick Ivan
        • Kozlowski Piotr B.
        • Bodis-Wollner Ivan
        The avascular zone and neuronal remodeling of the fovea in Parkinson disease.
        Ann Clin Transl Neurol. 2015 Feb; 2: 196-201
        • Eraslan M.
        • Cerman E.
        • Yildiz Balci S.
        • Celiker H.
        • Sahin O.
        • Temel A.
        • Suer D.
        • Tuncer Elmaci N.
        The choroid and lamina cribrosa is affected in patients with Parkinson's disease: enhanced depth imaging optical coherence tomography study.
        Acta Ophthalmol. 2016 Feb; 94: e68-e75
        • Garcia-Martin E.
        • Pablo L.E.
        • Bambo M.P.
        • Alarcia R.
        • Polo V.
        • Larrosa J.M.
        • Vilades E.
        • Cameo B.
        • Orduna E.
        • Ramirez T.
        • Satue M.
        Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease.
        PLoS One. 2017 May 16; 12e0177163
        • La Morgia C.
        • Di Vito L.
        • Carelli V.
        • Carbonelli M.
        Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs magnocellular degeneration in optical coherence tomography studies.
        Front. Neurol. 2017 Dec 22; 8: 710
        • La Morgia C.
        • Ross-Cisneros F.N.
        • Sadun A.A.
        • Carelli V.
        Retinal ganglion cells and circadian rhythms in Alzheimer's disease, Parkinson's disease, and beyond.
        Front. Neurol. 2017 May 4; 8: 162
        • Beach T.G.
        • Carew J.
        • Serrano G.
        • Adler C.H.
        • Shill H.A.
        • Sue L.I.
        • Sabbagh M.N.
        • Akiyama H.
        • Cuenca N.
        • Arizona Parkinson's Disease Consortium
        Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
        Neurosci Lett. 2014 Jun 13; 571: 34-38
        • Bodis-Wollner I.
        • Kozlowski P.B.
        • Glazman S.
        • Miri S.
        α-Synuclein in the inner retina in parkinson disease.
        Ann. Neurol. 2014 Jun; 75: 964-966
        • Giannoccaro M.P.
        • La Morgia C.
        • Rizzo G.
        • Carelli V.
        Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.
        Mov. Disord. 2017 Mar; 32: 346-363
        • Normando E.M.
        • Davis B.M.
        • De Groef L.
        • Nizari S.
        • Turner L.A.
        • Ravindran N.
        • Pahlitzsch M.
        • Brenton J.
        • Malaguarnera G.
        • Guo L.
        • Somavarapu S.
        • Cordeiro M.F.
        The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
        Acta Neuropathol Commun. 2016 Aug 18; 4: 86
        • Wolf-Schnurrbusch U.E.
        • Ceklic L.
        • Brinkmann C.K.
        • Iliev M.E.
        • Frey M.
        • Rothenbuehler S.P.
        • Enzmann V.
        • Wolf S.
        Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.
        Invest. Ophthalmol. Vis. Sci. 2009 Jul; 50: 3432-3437
        • Matlach J.
        • Wagner M.
        • Malzahn U.
        • Göbel W.
        Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices.
        Invest. Ophthalmol. Vis. Sci. 2014 Sep 16; 55: 6536-6546
        • Lee E.S.
        • Kang S.Y.
        • Choi E.H.
        • Kim J.H.
        • Kim N.R.
        • Seong G.J.
        • Kim C.Y.
        Comparisons of nerve fiber layer thickness measurements between stratus, cirrus, and RTVue OCTs in healthy and glaucomatous eyes.
        Optom. Vis. Sci. 2011 Jun; 88: 751-758
        • Leite M.T.
        • Rao H.L.
        • Weinreb R.N.
        • Zangwill L.M.
        • Bowd C.
        • Sample P.A.
        • Tafreshi A.
        • Medeiros F.A.
        Agreement among spectral-domain optical coherence tomography instruments for assessing retinal nerve fiber layer thickness.
        Am J Ophthalmol. 2011 Jan; 151 (85–92.e1)
        • Bock M.
        • Brandt A.U.
        • Dörr J.
        • Pfueller C.F.
        • Ohlraun S.
        • Zipp F.
        • Paul F.
        Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study.
        Mult. Scler. 2010 Jul; 16: 893-896https://doi.org/10.1177/1352458510365156
        • Knight O.J.
        • Girkin C.A.
        • Budenz D.L.
        • Durbin M.K.
        Feuer WJ; cirrus OCT normative database study group. Effect of race, age, and axial length on optic nerve head parameters and retinal nerve fiber layer thickness measured by cirrus HD-OCT.
        Arch. Ophthalmol. 2012; 130: 312-318
        • Tewarie P.
        • Balk L.
        • Costello F.
        • Green A.
        • Martin R.
        • Schippling S.
        • Petzold A.
        The OSCAR-IB consensus criteria for retinal OCT quality assessment.
        PLoS One. 2012; 7 (doi: 10.1371)e34823
        • Schippling S.
        • Balk L.J.
        • Costello F.
        • Albrecht P.
        • Balcer L.
        • Calabresi P.A.
        • Frederiksen J.L.
        • Frohman E.
        • Green A.J.
        • Klistorner A.
        • Outteryck O.
        • Paul F.
        • Plant G.T.
        • Traber G.
        • Vermersch P.
        • Villoslada P.
        • Wolf S.
        • Petzold A.
        Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
        Mult. Scler. 2015 Feb; 21: 163-170https://doi.org/10.1177/1352458514538110
        • Cruz-Herranz Andrés
        • Balk Lisanne J.
        • Oberwahrenbrock Timm
        • Albrecht Philipp
        • et al.
        The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.
        Neurology. 2016 Jun 14; 86: 2303-2309
        • Oertel F.C.
        • Kuchling J.
        • Zimmermann H.
        • Chien C.
        • Schmidt F.
        • Knier B.
        • Bellmann-Strobl J.
        • Korn T.
        • Scheel M.
        • Klistorner A.
        • Ruprecht K.
        • Paul F.
        • Brandt A.U.
        Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.
        Neurol Neuroimmunol Neuroinflamm. 2017 Feb 22; 4e334
        • Oertel F.C.
        • Zimmermann H.
        • Mikolajczak J.
        • Weinhold M.
        • Kadas E.M.
        • Oberwahrenbrock T.
        • Pache F.
        • Bellmann-Strobl J.
        • Ruprecht K.
        • Paul F.
        • Brandt A.U.
        Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.
        Neurol Neuroimmunol Neuroinflamm. 2017 Apr 18; 4e338